When directly compared with dulaglutide , an established GLP-1 agonist, retatrutide produced greater improvements in HbA1c, body weight and body-fat percentage, while maintaining a similar safety profile
A meta-analysis reported that T2DM patients treated with GLP-1RAs have a lower risk of Alzheimers disease than non-users (OR = 0.54, 95% CI, 0.300.96) [273]
15, 2025 -- For adults with type 2 diabetes mellitus (T2DM), glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy is associated with a reduced risk for epilepsy, according to a study published online Dec
The information provided in this article is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment
Stabiliteits- en oplosbaarheidsonderzoek van korte, sterk polaire peptiden onder gecontroleerde temperatuur- en pH-condities